The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis
BMC Medicine
15 January 2019
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-018-1242-0
Dr. Armin Schwarzbach, Infections in Cancer and Autoimmune Disorders. Presented by Markus Berger.
The Benefits of Low Dose Naltrexone
JewishLink
21 May 2020
https://jewishlink.news/monthly-sections/health-link-new/37942-the-benefits-of-low-dose-naltrexone
Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review
Curr Pain Headache Rep
26 Aug 2020
https://pubmed.ncbi.nlm.nih.gov/32845365/
Purpose of review: The purpose of this review is to evaluate and explain our current understanding of the clinical use of low-dose naltrexone in the treatment of chronic pain.
Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels
Arthritis Rheum
February 2013
https://pubmed.ncbi.nlm.nih.gov/23359310/
Low-Dose Naltrexone: An Inexpensive Medicine for Many Ills?
Medscape Medical News
11 Mar 2020
https://www.medscape.com/viewarticle/926611?src=WNL_trdalrt_201027_MSCPEDIT&uac=267476HJ&impID=2640101&f
Low-Dose Naltrexone Gaining Recognition as Chronic Pain Treatment
Pain News Network, 23 Nov 2020
https://www.painnewsnetwork.org/stories/2020/11/23/low-dose-naltrexone-gains-recognition-as-chronic-pain-treatment
Cory Tichauer, ND - LDN and Lyme Disease I (2017 Conference) (LDN, low dose naltrexone)
Dr Cory Tichauer shares his presentation on LDN and Lyme Disease at The LDN 2017 Conference.
Dr Tichauer begins by highlighting that Chronic Lyme Disease has many overlapping symptoms from PTLS but can also involve other organ dysfunction due to active infections still causing tissue damage.